ebook img

British Journal of Haematology 2002: Vol 119 Table of Contents PDF

17 Pages·2002·2.9 MB·English
by  
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview British Journal of Haematology 2002: Vol 119 Table of Contents

Volume Contents iii BRITISH JOURNAL OF HAEMATOLOGY Volume 119, Issue 1, October 2002 IMAGES IN HAEMATOLOGY Superior vena cava syndrome and hypercalcaemia in a patient with a primary mediastinal B-cell lymphoma secreting parathyroid hormone-related protein L.-T. Hsiao, T.-]. Chiou, .-T. Yu and P.-M. Chen Intravascular lymphomatosis of the prostate gland C. S. Chim and F. Loong REVIEWS Combination therapy with imatinib mesylate (STI571): synopsis of in vitro studies J. Topaly, W. J. Zeller and S. Fruehauf STI-571 in chronic myelogenous leukaemia A. S. Tsao, H. Kantarjian and M. Talpaz ANNOTATION Haematological care of the Jehovah's Witness patient J. C. W. Marsh and D. H. Bevan HAEMATOLOGICAL MALIGNANCY Bone marrow cyclooxygenase-2 levels are elevated in chronic-phase chronic myeloid leukaemia and are associated with reduced survival F. J. Giles, H. M. Kantarjian, B. N. Bekele, J. E. Cortes, S. Faderl, D. A. Thomas, T. Manshouri, A. Rogers, M. J. Keating, M. Talpaz, S. O'Brien and M. Albitar Low expression of interferon regulatory factor-1 and identification of novel exons skipping in patients with chronic myeloid leukaemia D. Tzoanopoulos, M. Speletas, K. Arvanitidis, C. Veiopoulou, S. Kyriaki, G. Thyphronitis, P. Sideras, G. Kartalis and K. Ritis Myeloma clonotypic B cells are hampered in their ability to undergo B-cell differentiation in vitro ]. E. J. Guikema, E. Vellenga, M. H. C. Bakkus and N. A. Bos Tumoral non-amyloidotic monoclonal immunoglobulin light chain deposits (‘aggregoma’): presenting feature of B-cell dyscrasia in three cases with immunohistochemical and biochemical analyses A. Rostagno, G. Frizzera, L. Ylagan, A. Kumar, J]. Ghiso and G. Gallo iv Volume Contents 70 CD106 and activated-CD29 are expressed on myelomatous bone marrow plasma cells and their downregulation is associated with tumour progression R. Luque, J. A. Garcia-Trujillo, C. Camara, A. Moreno, P. Eiras, G. Roy, L. M. Villar, M. Lombardia, J. A. Brieva, A. Bootello and E. Roldan Randomized, dose-finding study of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies M. Hedenus, S. Hansen, K. Taylor, C. Arthur, B. Emmerich, C. Dewey, D. Watson, G. Rossi and A. Osterborg on behalf of the Darbepoetin alfa 990114 Study Group Prognosis of myelodysplasic patients: non-parametric multiple regression analysis of populations stratified by mean corpuscular volume and marrow myeloblast number G. B. Tennant, A. I. Al-Sabah and A. K. Burnett 97 Molecular and flow cytometric characterization of the CD4 and CD8 T-cell repertoire in patients with myelodysplastic syndrome ]. J. Melenhorst, R. Eniafe, D. Follmann, R. Nakamura, M. Kirby and A. J. Barrett Short reports 106 Imatinib mesylate has limited activity against the central nervous system involvement of Philadelphia chromosome-positive acute lymphoblastic leukaemia due to poor penetration into cerebrospinal fluid N. Takayama, N. Sato, S. G. O'Brien, Y. Ikeda and S.-i. Okamoto 109 Mutation in the ATP-binding site of BCR-ABL in a patient with chronic myeloid leukaemia with increasing resistance to STI571 C. Barthe, M.-j. Gharbi, V. Lagarde, C. Chollet, P. Cony-Makhoul, J. Reiffers, ]. M. Goldman, J. V. Melo and F. X. Mahon Identification and characterization of a novel gene encoding a SEREX antigen in chronic myeloid leukaemia S. A. Rogers, D. J. Bowen, M. Ling, P. Thomson, Z. Wang and S. H. Lim Low blood dendritic cells in chronic myeloid leukaemia patients correlates with loss of CD34*°/CD38° primitive haematopoietic progenitors M. Mohty, D. Isnardon, N. Vey, F. Briére, D. Blaise, D. Olive and B. Gaugler Frequent co-expression of HoxA9 and Meis1 genes in infant acute lymphoblastic leukaemia with MLL rearrangement T. Imamura, A. Morimoto, M. Takanashi, S. Hibi, T. Sugimoto, E. Ishii and S. Imashuku Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma D. Molin, A. Edstrém, I. Glimelius, B. Glimelius, G. Nilsson, C. Sundstrém and G. Enblad Pure red cell aplasia due to parvovirus following treatment with CHOP and rituximab for B-cell lymphoma K. W. Song, P. Mollee, B. Patterson, W. Brien and M. Crump 128 Response to thalidomide in chemotherapy-resistant mantle cell lymphoma: a case report E. A. Wilson, S. Jobanputra, R. Jackson, A. N. Parker and I. G. McQuaker Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome N. T. Ueno, A. Anagnostopoulos, G. Rondon, R. E. Champlin, N. Mikhailova, O. S. Pankratova, L. S. Zoubarovskaya, E. V. Semenova, B. V. Afanasyev, S. O'Brien, M. Andreeff and A. Y. Zaritskey Volume Contents V TRANSPLANTATION Influence of the different CD34* and CD34" cell subsets infused on clinical outcome after non-myeloablative allogeneic peripheral blood transplantation from human leucocyte antigen-identical sibling donors P. Menéndez, J. A. Pérez-Simon, M. V. Mateos, M. D. Caballero, M. Gonzalez, ]. F. San-Miguel and A. Orfao Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced-intensity conditioning compared with standard preparative regimens J. E. Parker, T. Shafi, A. Pagliuca, A. Mijovic, S. Devereux, M. Potter, H. G. Prentice, M. Garg, J. A. Yin, J. Byrne, N. H. Russell and G. J. Mufti H2-mismatched transplantation with repetitive cell infusions and CD40 ligand antibody infusions without myeloablation ].-F. Lambert, G. A. Colvin, S. Zhong, H. Wang, L. D'Hondt, M. Abedi, A. E. Frimberger, F. M. Stewart and P. ]. Quesenberry Short report Cytotoxic chemotherapy following tandem autotransplants in multiple myeloma patients A. B.-T. Fassas, T. Spencer, R. Desikan, M. Zangari, E. Anaissie, B. Barlogie and G. Tricot PLATELETS, HAEMOSTASIS AND THROMBOSIS Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis A. van Hylckama Vlieg, N. Komanasin, R. A. S. Ariéns, S. R. Poort, P. J. Grant, R. M. Bertina and F. R. Rosendaal Short report Successful treatment of congenital thrombotic thrombocytopenic purpura using the intermediate purity factor VIII concentrate BPL 8Y W. A. Lester, M. D. Williams, S. L. Allford, M. S. Enayat and S. J. Machin HAEMOPOIESIS AND LEUCOCYTES Haemophagocytic lymphohistiocytosis: proposal of a diagnostic algorithm based on perforin expression M. Aricé, M. Allen, S. Brusa, R. Clementi, D. Pende, R. Maccario, L. Moretta and C. Danesino Human cytomegalovirus induces a direct inhibitory effect on antigen presentation by monocyte-derived immature dendritic cells U. Grigoleit, S. Riegler, H. Einsele, K. L. Sampaio, G. Jahn, H. Hebart, P. Brossart, F. Frank and C. Sinzger Human monocytes synthesize hyaluronidase N. Girard, C. Maingonnat, P. Bertrand, H. Tilly, J.-P. Vannier and B. Delpech Mobilization of dendritic cells in cancer patients treated with granulocyte colony-stimulating factor and chemotherapy F. J. Radcliff, D. A. Caruso, C. Koina, M. J. Riordan, A. W. Roberts, M. L. K. Tang, C. M. Baum, S. L. Woulfe and D. M. Ashley Laminin y2 chain as a stromal cell marker of the human bone marrow microenvironment U. Siler, P. Rousselle, C. A. Miiller and G. Klein vi Volume Contents Human Siglec-5: tissue distribution, novel isoforms and domain specificities for sialic acid-dependent ligand interactions N. P. Connolly, M. Jones and S. M. Watt Short report 239 Induction of the CD163-dependent haemoglobin uptake by macrophages as a novel anti-inflammatory action of glucocorticoids D. J. Schaer, F. S. Boretti, G. Schoedon and A. Schaffner RED CELLS 244 Influence of different radioprotective compounds on radiotolerance and cell cycle distribution of human progenitor cells of granulocytopoiesis in vitro W. Klingler, L. Kreja, W. Nothdurft and C. Selig Fetal RHD genotyping in maternal serum during the first trimester of pregnancy J.-M. Costa, Y. Giovangrandi, P. Ernault, L. Lohmann, V. Nataf, N. El Halali and E. Gautier Short reports Familial transient erythroblastopenia of childhood is associated with the chromosome 19q13.2 region but not caused by mutations in coding sequences of the ribosomal protein $19 (RPS19) gene P. Gustavsson, J. Klar, H. Matsson, E. Forestier, J.-I. Henter, S. Rao, M. Seip, G. Skeppner and N. Dahl 265 Unusual phenotypic observations associated with a rare HbH disease genotype (- Med /-yTSaudi «): implications for clinical management ]. Traeger-Synodinos, I. Papassotiriou, M. Karagiorga, E. Premetis, E. Kanavakis and A. Stamoulakatou CORRESPONDENCE 268 Position paper on imatinib mesylate in chronic myeloid leukaemia S. G. O'Brien and S. A. J]. Rule Nm| a Nm BCR-ABL FISH monitoring of CML: a survey of current UK practice M. W. Drummond, L. M. Hendry, E. Maher and T. L. Holyoake STI571-induced Stevens—Johnson syndrome D. Vidal, L. Puig, A. Sureda and A. Alomar Nm| a AT Thalidomide treatment of relapsed multiple myeloma patients and changes in circulating VEGF and bFGF V. Pitini, D. Teti, C. Arrigo, G. Aloi and M. Righi 276 Serum levels of VEGF do not correlate with the severity of multiple myeloma C. Jakob, I. Zavrski, U. Heider, C. Langelotz, J]. Eucker, K. Possinger and O. Sezer Reply to Sezer et al T. Iwasaki P15'%*** is not mutated in adult familial myelodysplastic syndromes E. Cameron, A. Mijovic, J. G. Herman, S. B. Baylin, A. Pradhan, G. J. Mufti and F. V. Rassool Red cell aplasia due to parvovirus B19 in a patient treated with alemtuzumab B. Crowley and B. Woodcock 280 Parvovirus B19-associated pure red cell aplasia in chronic graft-versus-host disease J]. W. Hsu, M. Czader, V. Anders, G. Vogelsang and R. A. Brodsky Volume Contents vii Congenital afibrinogenaemia in a newborn infant due to a novel mutation in the fibrinogen Aa gene J. J. Vlietman, J. Verhage, H. L. Vos, R. van Wijk, J. A. Remijn, W. W. van Solinge and F. Brus Relapse of severe aplastic anaemia after influenza immunization C. L. Hendry, M. Sivakumaran, J. C. W. Marsh and E. C. Gordon-Smith Acquired inhibitor of the intrinsic pathway in a non-haemophilic patient. Control of bleeding by recombinant factor Vila R. Lecumberri, C. Panizo, J. A. Paramo, M. P. Salazar and E. Rocha The use of recombinant factor Vila in a Jehovah's Witness with auto-immune thrombocytopenia and post-splenectomy haemorrhage D. P. Waddington, F. T. McAuley, J. P. Hanley and G. P. Summerfield ERRATA ANNOUNCEMENT Volume 119, Issue 2, November 2002 EDITORIAL IMAGES IN HAEMATOLOGY Pyothorax-associated lymphoma M. Yasukawa, M. Hamada and K. Ohshima Thrombus in harvested marrow from a patient with recent heparin-induced thrombocytopenia M. J. Bowers and F. G. C. Jones GUIDELINE The investigation and management of neonatal haemostasis and thrombosis M. D. Williams, E. A. Chalmers and B. E. S. Gibson REVIEWS Optimization of factor VIII replacement therapy: can structural studies help in evading antibody inhibitors? P. C. Spiegel Jr and B. L. Stoddard Factor VIII — novel insights into form and function E. L. Saenko, N. M. Ananyeva, E. G. D. Tuddenham and G. Kemball-Cook PLATELETS, HAEMOSTASIS AND THROMBOSIS The uptake of recombinant factor VIII in the Netherlands J. E. F. Zwart-van Rijkom, I. Plug, F. R. Rosendaal, H. G. M. Leufkens and A. W. Broekmans on behaolf fth e Study Group of Haemophilia in the Netherlands viii Volume Contents 342 Antibodies to factor Vila in patients with haemophilia and high-responding inhibitors ]. Astermark, M. Ekman and E. Berntorp 348 Human platelet alloantigen polymorphism in Glanzmann’s thrombasthenia and its impact on the severity of the disease K. Ghosh, B. Kulkarni, S. Nair, S. Shetty and D. Mohanty Platelet autoantibodies and lupus-associated thrombocytopenia M. Michel, K. Lee, J.-C. Piette, P. Fromont, A. Schaeffer, P. Bierling and B. Godeau 359 Expression of stanniocalcin-1 in megakaryocytes and platelets M. Serlachius, R. Alitalo, H. S. Olsen and L. C. Andersson 364 Lupus anticoagulant testing: improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods I. Jennings, M. Greaves, I. ]. Mackie, S. Kitchen, T. A. L. Woods and F. E. Preston on behalf of the UK National External Quality Assessment Scheme for Blood Coagulation 370 Reliability of point-of-care prothrombin time testing in a community clinic: a randomized crossover comparison with hospital laboratory testing C. R. Shiach, B. Campbell, L. Poller, M. Keown and N. Chauhan A family of textilinin genes, two of which encode proteins with antihaemorrhagic properties I. Filippovich, N. Sorokina, P. P. Masci, J. de Jersey, A. N. Whitaker, D. J. Winzor, P. J. Gaffney and M. F. Lavin w oe 41 C-reactive protein in the diagnosis of deep vein thrombosis R. A. Bucek, M. Reiter, P. Quehenberger and E. Minar Short reports 390 Factor VIII deficiency not induced by FVIII gene mutation in a female first cousin of two brothers with haemophilia A C. Mazurier, A. Parquet-Gernez, C. Gaucher, J.-M. Lavergne and J. Goudemand 393 Analysis of factor VIII inhibitors in a haemophilia A patient with an Arg’?* > Cys mutation using phage display W. S. Bril, E. A. M. Turenhout, P. H. P. Kaijen, E. N. van den Brink, M. M. W. Koopman, M. Peters and J. Voorberg 397 Severe methylenetetrahydrofolate reductase deficiency revealed by a pulmonary embolism in a young adult C. Tonetti, M. Ruivard, V. Rieu, J. Zittoun and S. Giraudier HAEMATOLOGICAL MALIGNANCY 400 Monensin-mediated growth inhibition in human lymphoma cells through cell cycle arrest and apoptosis W. H. Park, J. G. Seol, E. S. Kim, W. K. Kang, Y. H. Im, C. W. Jung, B. K. Kim and Y. Y. Lee 408 The value of bone marrow examination in the staging of Hodgkin's lymphoma: a review of 955 cases seen in a regional cancer centre S. J. Howell, M. Grey, J. Chang, G. R. Morgenstern, R. A. Cowan, D. P. Deakin and J. A. Radford 412 Incidence and nature of CD20-negative relapses following rituximab therapy in aggressive B-cell non-Hodgkin's lymphoma: a retrospective review G. A. Kennedy, S.-K. Tey, R. Cobcroft, P. Marlton, G. Cull, K. Grimmett, D. Thomson and D. Gill 417 Major histocompatibility complex abnormalities in non-Hodgkin lymphomas B. Drénou, G. Le Friec, M. Bernard, C. Pangault, J.-M. Grosset, T. Lamy, R. Fauchet and L. Amiot Volume Contents ix Differentiation of anti-tumour cytotoxic T lymphocytes from autologous peripheral blood lymphocytes in non-Hodgkin's lymphomas L. Chaperot, O. Manches, J. Q. Mi, A. Moine, M.-C. Jacob, R. Gressin, J.-P. Molens, ].-]. Sotto, D. Leroux, J.-C. Bensa and J. Plumas Hodgkin’s disease in the elderly: a population-based study G. L. Stark, K. M. Wood, F. Jack, B. Angus, S. J. Proctor and P. R. Taylor on behalf of the Northern Region Lymphoma Group Isolated parenchymal lung involvement in children with stage IV Hodgkin's disease: results of the UKCCSG HD8201 and HD9201 studies A. Atra, E. Higgs, M. Capra, A. Elsworth, J. Imeson, M. Radford, R. Pinkerton and M. Hewitt on behalf of the United Kingdom Children Cancer Study Group (UKCCSG)/Hodgkin's Disease Group Prospective molecular monitoring of BCR/ABL transcript in children with Ph* acute lymphoblastic leukaemia unravels differences in treatment response G. Cazzaniga, M. Lanciotti, V. Rossi, D. Di Martino, M. Arico, M. G. Valsecchi, G. Basso, G. Masera, C. Micalizzi and A. Biondi Identification of an ETV6—ABL2 fusion transcript in combination with an ETV6 point mutation in a T-cell acute lymphoblastic leukaemia cell line F. Griesinger, A. Janke, M. Podleschny and S. K. Bohlander Autologous lymphocytes as vectors to target therapeutic radiation, using indium-114m, in patients with lymphoid cell malignancy R. A. Cowan, B. Murby, D. Gunton, S. E. Owens, K. P. Hoyes, H. L. Sharma, A. M. Smith, J. Chang, B. van Kessel, P. M. Nuttall and D. Crowther Autocrine and/or paracrine growth of adult T-cell leukaemia tumour cells by interleukin 15 T. Kukita, N. Arima, K. Matsushita, K. Arimura, H. Ohtsubo, Y. Sakaki, H. Fujiwara, A. Ozaki, T. Matsumoto and C. Tei Pamidronate causes apoptosis of plasma cells in vivo in patients with multiple myeloma S. Gordon, M. H. Helfrich, H. I. A. Sati, M. Greaves, S. H. Ralston, D. J. Culligan, R. L. Soutar and M. J. Rogers Short reports Limitations of Gallium-67 SPECT in histological transformation of chronic lymphocytic leukaemia: an analysis of 13 patients with clinically suspected Richter’s syndrome F. Cobo, L. Rosinol, A. Martinez, F. Martin, J. Esteve, M. Gomez, E. Nadal, F. Bosch, F. J]. Setoain, E. Campo and E. Montserrat Molecular cytogenetics characterization of a novel translocation involving chromosomes 17 and 19 in a Ph* adult acute lymphoblastic leukaemia G. Specchia, F. Albano, L. Anelli, C. T. Storlazzi, G. Cimino, A. Liso, A. Zagaria, V. Liso and M. Rocchi CXCL13 (BCA-1) is produced by follicular lymphoma cells: role in the accumulation of malignant B cells H. Husson, A. S. Freedman, A. A. Cardoso, J. Schultze, O. Munoz, G. Strola, J. Kutok, E. G. Carideo, R. De Beaumont, F. Caligaris-Cappio and P. Ghia Nephrotic proteinuria associated with high-dose pamidronate in multiple myeloma R. Desikan, Y. Veksler, S. Raza, B. Stokes, T. Sabir, Z. Li and S. Jagannath HAEMOPOIESIS AND LEUCOCYTES Influence of cell cycling and cell division on transendothelial migration of CD34" cells K. L. Yong, A. Fahey, A. Pizzey and D. C. Linch xX Volume Contents 510 Developmental changes in the expression of transcription factors GATA-1, -2 and -3 during the onset of human medullary haematopoiesis C. Dame, M. C. Sola, J. Fandrey, L. M. Rimsza, P. Freitag, G. Knépfle, R. D. Christensen and J. Bungert 516 AC133° umbilical cord blood progenitors demonstrate rapid self-renewal and low apoptosis N. Forraz, R. Pettengell, P.-A. Deglesne and C. P. McGuckin JIN M JI Reconstitution of human haematopoiesis in non-obese diabetic/severe combined immunodeficient mice by clonal cells expanded from single CD34*CD38" cells expressing Fik2/FIt3 Y. Ebihara, M. Wada, T. Ueda, M.-j. Xu, A. Manabe, R. Tanaka, M. Ito, H. Mugishima, S. Asano, T. Nakahata and K. Tsuji Short report 41 w v1 Dominant expression of interleukin 10 but not interferon y in CD4°"CD8" afT cells of autoimmune lymphoproliferative syndrome S. Ohga, A. Nomura, Y. Takahata, K. Ihara, H. Takada, H. Wakiguchi, Y. Kudo and T. Hara RED CELLS AND IRON Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3) M. Cazzola, L. Cremonesi, M. Papaioannou, N. Soriani, A. Kioumi, A. Charalambidou, R. Paroni, K. Romtsou, S. Levi, M. Ferrari, P. Arosio and J. Christakis Effective binding of free iron by a single intravenous dose of human apotransferrin in haematological stem cell transplant patients L. Sahlstedt, L. von Bonsdorff, F. Ebeling, T. Ruutu and J. Parkkinen Rapid detection of the major Mediterranean $-thalassaemia mutations by real-time polymerase chain reaction using fluorophore-labelled hybridization probes I. Moreno, P. Bolufer, M. L. Perez, E. Barragan and M. A. Sanz Exploring polycythaemia vera with fluorescence in situ hybridization: additional cryptic 9p is the most frequent abnormality detected V. Najfeld, L. Montella, A. Scalise and S. Fruchtman Chronic leg ulceration in homozygous sickle cell disease: the role of venous incompeience A. Clare, M. FitzHenley, J]. Harris, I. Hambleton and G. R. Serjeant CORRESPONDENCE V1 Piebaldism in Diamond-Blackfan anaemia: a new phenotype? L. D. A. Costa, J. Fixler, O. Berets, T. Leblanc, T.-N. Willig, N. Mohandas and G. Tchernia JI “I w Successful umbilical cord blood transplantation in a child with dyskeratosis congenita after a fludarabine-based reduced-intensity conditioning regimen B. Nobili, G. Rossi, P. De Stefano, M. Zecca, G. Giorgiani, S. Perrotta, A. Canazzio and F. Locatelli JI 1 Hyperbaric oxygen for cyclophosphamide-induced cystitis M. J. Hughes, F. M. Davis, S. D. Mark and R. L. Spearing 5/6 Severe increase in creatinine with hypocalcaemia in thalidomide-treated myeloma patients receiving zoledronic acid infusions S. G. Jones, G. Dolan, K. Lengyel and B. Myers Volume Contents xi Treatment of refractory autoimmune (acquired) haemophilia with anti-CD20 (Rituximab) S. Kain, T.-S. Copeland and M. F. Leahy Is high expression of the chemokine receptor CXCR-4 of predictive value for early relapse in childhood acute lymphoblastic leukaemia? P. Schneider, M. Vasse, A. Al Bayati, B. Lenormand and J.-P. Vannier BOOK REVIEW Volume 119, Issue 3, December-I 2002 IMAGES IN HAEMATOLOGY Alveolar rhabdomyosarcoma with bone marrow infiltration mimicking haematological neoplasia O. Maywald, G. Metzgeroth, C. Schoch, W. D. Ludwig, W. Neff, R. Hehlmann and J. Hastka Papillary endothelial hyperplasia in a bone marrow transplant recipient with extensive chronic graft-versus-host disease T. Yoshihara, T. Chiyonobu, A. Tatebe, A. Morimoto and S. Imashuku REVIEWS X-linked lymphoproliferative disease: clinical, diagnostic and molecular perspective H. B. Gaspar, R. Sharifi, K. C. Gilmour and A. J. Thrasher Prevention and treatment of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of bone marrow and solid organ transplants E. Meijer, A. W. Dekker, A. J. L. Weersink, M. Rozenberg-Arska and L. F. Verdonck HAEMATOLOGICAL MALIGNANCY Potassium antimony] tartrate induces caspase- and reactive oxygen species-dependent apoptosis in lymphoid tumoral cells V. Lecureur, A. Le Thiec, A. Le Meur, L. Amiot, B. Drenou, M. Bernard, T. Lamy, R. Fauchet and O. Fardel Specificity of polymerase chain reaction-based clonality analysis of immunoglobulin heavy chain gene rearrangement for the detection of bone marrow infiltrate in B-cell lymphoma-associated haemophagocytic syndrome K. Kojima, K. Kaneda, M. Yasukawa, K. Tanaka, T. Inoue, T. Yamashita, H. Dansako, S. T. Sakugawa, T. Kozuka, M. Hara and M. Tanimoto Molecular histogenesis of plasmablastic lymphoma of the oral cavity G. Gaidano, M. Cerri, D. Capello, E. Berra, C. Deambrogi, D. Rossi, L. M. Larocca, E. Campo, A. Gloghini, U. Tirelli and A. Carbone Intraclonal diversity in a Sezary syndrome with a differential response to 2-deoxycoformycin of the two lymphoma cell populations E. Granjo, M. Lima, J. M. Lopes, N. Cunha, M. A. Teixeira, F. Santos, J. Candeias, C. Resende, A. H. Santos, A. Balanzategui, A. Orfao and E. Matutes xii Volume Contents 634 Treatment results of aggressive B non-Hodgkin's lymphoma in advanced age considering comorbidity R. Sonnen, W.-P. Schmidt, R. Kuse and N. Schmitz 640 An unbalanced translocation involving chromosome 14 is the probable cause for loss of potentially functional rearranged immunoglobulin heavy chain genes in the Epstein-Barr virus-positive Hodgkin’s lymphoma-derived cell line L591 M. Vockerodt, G. Belge, D. Kube, J. Irsch, R. Siebert, H. Tesch, V. Diehl, J]. Wolf, ]. Bullerdiek and A. Staratschek-Jox 647 ChIVPP chemotherapy in children with stage IV Hodgkin's disease: results of the UKCCSG HD 8201 and HD 9201 studies A. Atra, E. Higgs, M. Capra, A. Elsworth, J. Imeson, M. Radford and M. Hewitt on behalf of the UKCCSG/Hodgkin's Disease Group 652 rHuEpo administration in patients with low-risk myelodysplastic syndromes: evaluation of erythroid precursors’ response by fluorescence in situ hybridization on May-—Grunwald-Giemsa-stained bone marrow samples G. M. Rigolin, M. D. Porta, R. Bigoni, F. Cavazzini, M. Ciccone, A. Bardi, A. Cuneo and G. Castoldi 660 Anti-myeloma activity of natural killer lymphocytes C. Frohn, M. Hoéppner, P. Schlenke, H. Kirchner, P. Koritke and J. Luhm 665 Bone marrow angiogenesis in multiple myeloma: effect of therapy S. Kumar, R. Fonseca, A. Dispenzieri, M. Q. Lacy, J. A. Lust, T. E. Witzig, M. A. Gertz, R. A. Kyle, P. R. Greipp and S. V. Rajkumar 672 Hepatocyte growth factor in myeloma patients treated with high-dose chemotherapy C. Seidel, S. Lenhoff, S. Brabrand, G. Anderson, T. Standal, J. Lanng-Nielsen, I. Turesson, M. Berset and A. Waage for the Nordic Myeloma Study Group Soluble .-selectin (sCD62L) in relapsed childhood acute lymphoblastic leukaemia R. Herold, D. Stibenz, R. Hartmann, G. Henze and C. Biihrer 685 Polymerase chain reaction (PCR)- and reverse transcription PCR-based minimal residual disease detection in long-term follow-up of childhood acute lymphoblastic leukaemia P. Gameiro, I. Moreira, S. Yetgin, M. Papaioannou, M. N. Potter, H. G. Prentice, A. V. Hoffbrand and L. Foroni 697 Comparison of a specialist haematological malignancy database against a regional cancer registry: case ascertainment and diagnostic accuracy K. Phekoo, H. Meller, M. Richards and S. Schey 706 Helicobacter pylori infection and monoclonal gammopathy of undetermined significance S. V. Rajkumar, R. A. Kyle, M. F. Plevak, J. A. Murray and T. M. Therneau 709 Plasma matrix metalloproteinase and tissue inhibitor of metalloproteinase in patients with agnogenic myeloid metaplasia or idiopathic primary myelofibrosis J. C. Wang, A. Novetsky, C. Chen and A. D. Novetsky High occurence of DRB1 11 in chronic lymphocytic leukaemia families I. Theodorou, L. Abel, F. Mauro, B. Duprey, C. Magnac, B. Payelle-Brogard, F. Davi and G. Dighiero 716 Multilineage involvement in hypereosinophilic syndrome terminating in granulocytic sarcoma and leukaemic transformation with trisomy 8 N. Fujii, K. Ikeda, N. Takahashi, K. Kojima, Y. Kobayashi, A. Ashiba, K. Takenaka, S. Fukuda, K. Shinagawa, F. Ishimaru, K. Niiya, I. Miura, M. Tanimoto and M. Harada

See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.